Abstract
With the upgraded innovations in material science and translational medicine, micro-/nanoimaging probes show great promises for clinical translations to serve human healthcare. A number of micro-/nanoimaging probes have been approved for clinical imaging in US, CT, PET, SPECT, etc., and tremendous agents are at the status of clinical trials or under translations. This chapter focuses on the current commercially available imaging probes and their biomedical roles in disease diagnosis for patients. The potential challenges and future perspectives of imaging probes under evaluation are also briefly disclosed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kurup, N., Naik, P.: Microbubbles: a novel delivery system. Asian J. Pharm. Res. Healthc. 2, 228 (2013)
Hitesh, J., Parth, P., Suraj, F., Prachi, P., Shikha, Y.: Microbubbles-a potential ultrasound tool in drug delivery. Asian J. Pharm. Clin. Res. 4, 6–11 (2011)
Patel, R.M.: Microbubble: an ultrasound contrast agent in molecular imaging. Pharma Times 40, 15–19 (2008)
Palekar-Shanbhag, P., Chogale, M.M., Jog, S.V., Gaikwad, S.S.: Microbubbles and their applications in pharmaceutical targeting. Curr. Drug Deliv. 10, 363–373 (2013)
Ittrich, H., Peldschus, K., Raabe, N., Kaul, M., Adam, G.: Superparamagnetic iron oxide nanoparticles in biomedicine: Applications and developments in diagnostics and therapy. RoFo: Fortschritte auf dem Gebiete der Roentgenstrahlen und der Nuklearmedizin 185, 1149–1166 (2013)
Lee, N., Choi, S.H., Hyeon, T.: Nano-sized ct contrast agents. Adv. Mater. 25, 2641–2660 (2013)
Bean, C.P., Livingston, J.D.: Superparamagnetism. J. Appl. Phys. 30, S120–S129 (1959)
Schoonman, J.: Nanostructured materials in solid state ionics. Solid State Ionics 135, 5–19 (2000)
Kemsheadl, J.T., Ugelstad, J.: Magnetic separation techniques: their application to medicine. Mol. Cell. Biochem. 67, 11–18 (1985)
Hemmingsson, A., Carlsten, J., Ericsson, A., Klaveness, J., Sperber, G.O., Thuomas, K.A.: Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging. Acta Radiol. 28, 703–705 (1987)
Josephson, L., Lewis, J., Jacobs, P., Hahn, P.F., Stark, D.D.: The Effects of Iron Oxides on Proton Relaxivity. Prentice-Hall (1988)
Rubin, G.D., Rofsky, N.M.: CT and MR Angiography: Comprehensive Vascular Assessment. Lippincott Williams & Wilkins (2008)
Molinari, F., Fink, C., Risse, F., Tuengerthal, S., Bonomo, L., Kauczor, H.U.: Assessment of differential pulmonary blood flow using perfusion magnetic resonance imaging: comparison with radionuclide perfusion scintigraphy. Invest. Radiol. 41, 624 (2006)
Ohno, Y., Hatabu, H., Higashino, T., Takenaka, D., Watanabe, H., Nishimura, Y., Yoshimura, M., Sugimura, K.: Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. Am. J. Roentgenol. 182, 73–78 (2004)
Iwasawa, T., Saito, K., Ogawa, N., Ishiwa, N., Kurihara, H.: Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung. J. Magn. Reson. Imaging 15, 685–692 (2002)
Weinsaft, J.W., Klem, I., Judd, R.M.: MRI for the assessment of myocardial viability. Cardiol. Clin. 25, 505–525 (2007)
Sakuma, H.: Magnetic resonance imaging for ischemic heart disease. J. Magn. Reson. Imaging 26, 3–13 (2007)
Saslow, D., Harms, S., Leach, M.O., Morris, E., Pisano, E., Sener, S.: American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA-A Cancer J. Clin. 57, 75 (2007)
Moon, M., Cornfeld, D., Weinreb, J.: Dynamic contrast-enhanced breast MR imaging. Magn. Reson. Imaging Clin. N. Am. 17, 351–362 (2009)
Fidler, J.: MR imaging of the small bowel. Radiographics 29, 1811–1825 (2009)
Schneider, G., Reimer, P., Mamann, A., Kirchin, M.A., Morana, G., Grazioli, L.: Contrast agents in abdominal imaging: current and future directions. Topics Magn. Reson. Imaging 16, 107–124 (2005)
Hricak, H., Chen, M., Coakley, F.V., Kinkel, K., Yu, K.K., Sica, G., Bacchetti, P., Powell, C.B.: Complex adnexal masses: detection and characterization with MR imaging–multivariate analysis. Radiology 214, 39 (2000)
Whitten, C.R., Desouza, N.M.: Magnetic resonance imaging of uterine malignancies. Topics Magn. Reson. Imaging. 17, 365–377 (2006)
Manfredi, R., Gui, B., Maresca, G., Fanfani, F., Bonomo, L.: Endometrial cancer: magnetic resonance imaging. Abdom. Imaging 30, 626–636 (2005)
Sohaib, S.A., Sahdev, A., Van, T.P., Jacobs, I.J., Reznek, R.H.: Characterization of adnexal mass lesions on MR imaging. Am. J. Roentgenol. 180, 1297–1304 (2003)
Calero, M., Gutierrez, L., Salas, G., Luengo, Y., Lazaro, A., Acedo, P., Morales, M.P., Miranda, R., Villanueva, A.: Efficient and safe internalization of magnetic iron oxide nanoparticles: Two fundamental requirements for biomedical applications. Nanomed. Nanotech. Biol. Med. 10, 733–743 (2014)
Weissleder, R., Elizondo, G., Wittenberg, J., Lee, A.S., Josephson, L., Brady, T.J.: Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175, 494–498 (1990)
Seneterre, E., Weissleder, R., Jaramillo, D., Reimer, P., Lee, A.S., Brady, T.J., Wittenberg, J.: Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 179, 529 (1991)
Schmitz, S.A., Winterhalter, S., Schiffler, S., Gust, R., Wagner, S., Kresse, M., Coupland, S.E., Semmler, W., Wolf, K.J.: Uspio-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 221, 237 (2001)
Schmitz, S.A., Coupland, S.E., Gust, R., Winterhalter, S., Wagner, S., Kresse, M., Semmler, W., Wolf, K.J.: Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in watanabe hereditable hyperlipidemic rabbits. Invest. Radiol. 35, 460–471 (2000)
Hahn, P.F., Stark, D.D., Weissleder, R., Elizondo, G., Saini, S., Ferrucci, J.T.: Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 174, 361–366 (1990)
Kent, T.A., Quast, M.J., Kaplan, B.J., Lifsey, R.S., Eisenberg, H.M.: Assessment of a superparamagnetic iron oxide (AMI-25) as a brain contrast agent. Magn. Reson. Med. 13, 434–443 (1990)
Vellinga, M.M., Oude, E., Seewann, A., Pouwels, P., Wattjes, P., van der Pol, S.M., Pering, C., Polman, C., de Vries, H., Geurts, J., Barkhof, F.: Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800–807 (2008)
Ferrucci, J.T., Stark, D.D.: Iron oxide-enhanced mr imaging of the liver and spleen: review of the first 5 years. Am. J. Roentgenol. 155, 943–950 (1990)
Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M.: Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32, 205–212 (2000)
Pultrum, B.B., Ej, V.D.J., van Westreenen, H.L., van Dullemen, H.M., Kappert, P., Groen, H., Sietsma, J., Oudkerk, M., Plukker, J.T., van Dam, G.M.: Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging 9, 19–28 (2009)
Nguyen, B.C., Stanford, W., Thompson, B.H., Rossi, N.P., Kernstine, K.H., Kern, J.A., Robinson, R.A., Amorosa, J.K., Mammone, J.F., Outwater, E.K.: Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J. Magn. Reson. Imaging 10, 468–473 (1999)
Tokuhara, T., Tanigawa, N., Matsuki, M., Nomura, E., Mabuchi, H., Lee, S.W., Tatsumi, Y., Nishimura, H., Yoshinaka, R., Kurisu, Y.: Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 11, 194–200 (2008)
Ruehm, S.G., Corot, C., Vogt, P., Kolb, S., Debatin, J.F.: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415 (2001)
Kooi, M.E., Cappendijk, V.C., Cleutjens, K.B., Kessels, A.G., Kitslaar, P.J., Borgers, M., Frederik, P.M., Daemen, M.J., van Engelshoven, J.M.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453–2458 (2003)
Hahn, P.F., Stark, D.D., Ferrucci, J.T.: Accumulation of iron oxide particles around liver metastases during MR imaging. Gastrointest. Radiol. 17, 173–174 (1992)
Moore, A., Marecos, E., Bogdanov Jr., A., Weissleder, R.: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214, 568–574 (2000)
Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H.P., Modder, U., Jander, S.: In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670–1677 (2004)
Enochs, W.S., Harsh, G., Hochberg, F., Weissleder, R.: Improved delineation of human brain tumors on mr images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9, 228–232 (1999)
Eniola, A.O., Willcox, P.J., Hammer, D.A.: Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys. J. 85, 2720–2731 (2003)
Liu, Y., Miyoshi, H., Nakamura, M.: Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J. Control. Release 114, 89–99 (2006)
Amberg, J.R., Thompson, W.M., Golberger, L., Williamson, S., Alexander, R., Bates, M.: Factors in the intestinal absorption of oral cholecystopaques. Invest. Radiol. 15, S136 (1980)
Berk, R.N., Loeb, P.M.: Pharmacology and physiology of the biliary radiographic contrast materials. Semin. Roentgenol. 11, 147–156 (1976)
Berk, R.N., Loeb, P.M., Cobo-Frenkel, A., Barnhart, J.L.: The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: Pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid. Invest. Radiol. 12, 85 (1977)
Janes, J.O., Dietschy, J.M., Berk, R.N., Loeb, P.M., Barnhart, J.L.: Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum. Gastroenterology 76, 970–977 (1979)
Chilton, C., Swanson, D., Chilton, H., Thrall, J.: Pharmaceuticals in Medical Imaging. Macmillan Publishing Co. (1990)
Sovak, M., Hoey, G.B., Smith, K.R.: Radiocontrast agents. Handb. Exp. Pharmacol. 73, 1–125 (1984)
Dawson, P., Cosgrove, D.O., Grainger, R.G.: Textbook of Contrast Media. Isis Medical Media, Calif (1999)
Siegel, R.L., Miller, K.D., Jemal, A.: Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29 (2015)
Talbot, J.N., Fartoux, L., Balogova, S., Nataf, V., Kerrou, K., Gutman, F., Huchet, V., Ancel, D., Grange, J.D., Rosmorduc, O.: Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J. Nucl. Med. 51, 1699–1706 (2010)
How, K.N., Dugue, A.E., Sevin, E., Allouache, N., Lesaunier, F., Joly, F., Aide, N.: Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. Nucl. Med. Commun. 37, 348–355 (2016)
Garcia, V., Jimenez, A., Villena, M., Jimenez, L., Borras, M.: 18F-fluorocholine PET/CT, brain MRI, and 5-aminolevulinic acid for the assessment of tumor resection in high-grade glioma. Clin. Nucl. Med. 42, e300–e303 (2017)
Balogova, S., Huchet, V., Kerrou, K., Nataf, V., Gutman, F., Antoine, M., Ruppert, A., Prignon, A., Lavolee, A., Montravers, F., Mayaud, C., Cadranel, J., Talbot, J.: Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose. Nucl. Med. Commun. 31, 389–397 (2010)
Are, C., Meyer, B., Stack, A., Ahmad, H., Smith, L., Qian, B., Song, T., Chowdhury, S.: Global trends in the burden of liver cancer. J. Surg. Oncol. 115, 591–602 (2017)
Kubota, R., Kubota, K., Yamada, S., Tada, M., Takahashi, T., Iwata, R., Tamahashi, N.: Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J. Nucl. Med. 36, 484–492 (1995)
Buroni, F.E., Pasi, F., Persico, M.G., Lodola, L., Aprile, C., Nano, R.: Evidence of 18F-FCH uptake in human T98G glioblastoma cells. Anticancer Res. 35, 6439–6443 (2015)
Bejanin, A., Schonhaut, D.R., La Joie, R., Kramer, J.H., Baker, S.L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., O’Neil, J.P., Gorno-Tempini, M.L., Miller, Z.A., Rosen, H.J., Miller, B.L., Jagust, W.J., Rabinovici, G.D.: Tau pathology and neurodegeneration contribute to cognitive impairment in alzheimer’s disease. Brain 140, 3286–3300 (2017)
Kang, J.M., Lee, S.Y., Seo, S., Jeong, H.J., Woo, S.H., Lee, H., Lee, Y.B., Yeon, B.K., Shin, D.H., Park, K.H., Kang, H., Okamura, N., Furumoto, S., Yanai, K., Villemagne, V.L., Seong, J.K., Na, D.L., Ido, T., Cho, J., Lee, K.M., Noh, Y.: Tau positron emission tomography using [(18)F]THK5351 and cerebral glucose hypometabolism in alzheimer’s disease. Neurobiol. Aging 59, 210–219 (2017)
Ueno, A., Masugi, Y., Yamazaki, K., Komuta, M., Effendi, K., Tanami, Y., Tsujikawa, H., Tanimoto, A., Okuda, S., Itano, O., Kitagawa, Y., Kuribayashi, S., Sakamoto, M.: OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J. Hepatol. 61, 1080–1087 (2014)
Junking, M., Grainok, J., Thepmalee, C., Wongkham, S., Yenchitsomanus, P.T.: Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA. Tumour Biol. 39, 1010428317733367 (2017)
Piert, M., Montgomery, J., Kunju, L.P., Siddiqui, J., Rogers, V., Rajendiran, T., Johnson, T.D., Shao, X., Davenport, M.S.: 18F-choline PET/MRI: The additional value of pet for MRI-guided transrectal prostate biopsies. J. Nucl. Med. 57, 1065–1070 (2016)
Tardy, I., Pochon, S., Theraulaz, M., Emmel, P., Passantino, L., Tranquart, F., Schneider, M.: Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest. Radiol. 45, 573–578 (2010)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wu, S. et al. (2018). Translational Clinical Applications of Micro-/Nanoimaging Probes: Challenges and Perspectives. In: Liu, Z. (eds) Advances in Functional Micro-/Nanoimaging Probes. Engineering Materials. Springer, Singapore. https://doi.org/10.1007/978-981-10-4804-3_4
Download citation
DOI: https://doi.org/10.1007/978-981-10-4804-3_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4803-6
Online ISBN: 978-981-10-4804-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)